Skip to main content
$10.41 $0.52 (5.3%)

04:00 PM EST on 02/01/23

Editas Medicine (NASDAQ:EDIT)

CAPS Rating: 3 out of 5

Current Price $10.41 Mkt Cap $700.2M
Open $10.30 P/E Ratio 0.00
Prev. Close $10.41 Div. (Yield) $0.00 (0.0%)
Daily Range $9.78 - $10.62 Volume 12
52-Wk Range $7.71 - $21.60 Avg. Daily Vol. 2,084,174

Caps

How do you think NASDAQ:EDIT will perform against the market?

Add Stock to CAPS Watchlist

All Players

333 Outperform
11 Underperform
 

All-Star Players

51 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EDIT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Ficktory (29.41)
Submitted December 17, 2021

Gene editing will be a huge growth industry in the future of health care

LastPlaceLenny (24.79)
Submitted March 15, 2019

Not ready to take off yet, will out perform in long run, but not sure when that long run starts. Not this year.

NASDAQ:EDIT Summary

Fools bullish on NASDAQ:EDIT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about EDIT.

Recs

0
Member Avatar quist1 (< 20) Submitted: 9/29/2022 2:02:12 PM : Underperform Start Price: $12.16 NASDAQ:EDIT Score: +28.29

Good for tax harvesting, revisit next year, good stock with solid technology. Perhaps options, no rush, this market to risky, hold onto the proven ones for now you can always revisit these.

Recs

0
Member Avatar TMFbonefish (39.37) Submitted: 4/20/2022 5:05:28 PM : Underperform Start Price: $15.70 NASDAQ:EDIT Score: +25.28

So many red flags. Turnover at the top, questionable results, and other Crispr biotechs moving faster in the lab and through the FDA.

Recs

1
Member Avatar Ficktory (29.41) Submitted: 12/17/2021 9:26:04 AM : Outperform Start Price: $27.67 NASDAQ:EDIT Score: -51.65

Gene editing will be a huge growth industry in the future of health care

Leaderboard

Find the members with the highest scoring picks in EDIT.

Score Leader

Dobby62

Dobby62 (56.79) Score: +242.71

The Score Leader is the player with the highest score across all their picks in EDIT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SeriousK 28.79 3/9/2016 Underperform 5Y $42.70 -75.62% +106.05% +181.67 0 Comment
TimeToBuy 91.55 3/10/2016 Underperform 5Y $32.50 -67.97% +105.43% +173.40 0 Comment
nobody2013 < 20 3/10/2016 Underperform NS $26.79 -61.14% +107.18% +168.32 1 Comment
btechrisk11 < 20 4/16/2018 Underperform 3Y $34.93 -70.20% +53.85% +124.05 1 Comment
chushogi 62.99 1/9/2017 Underperform 5Y $18.05 -42.33% +81.03% +123.36 0 Comment
LastPlaceLenny 24.79 3/15/2019 Underperform 1Y $24.03 -56.68% +46.42% +103.10 1 Comment
hayrettin 72.37 1/18/2022 Underperform 5Y $20.59 -49.43% -10.29% +39.14 0 Comment
quist1 < 20 9/29/2022 Underperform 1Y $12.16 -14.39% +13.90% +28.29 1 Comment
Bigcaps19 70.26 9/30/2022 Underperform 5Y $12.09 -13.90% +13.54% +27.43 0 Comment
TMFbonefish 39.37 4/21/2022 Underperform 5Y $15.70 -33.69% -8.42% +25.28 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EDIT.